Get in Touch
Let's Build the Future of
Let's Build the Future of
Nucleoside Therapeutics
Whether you're an investor, strategic partner, or scientific collaborator — we'd like to hear from you.
Ways to Engage
We're open to conversations across the capital and partnership spectrum.
Investors
Seed round open. Connect to discuss Sunom's platform, pipeline, and capital plan.
Strategic Partners
Pharma and biotech collaborations — co-development, licensing, and research alliances.
Scientific Collaborators
KOLs, academic labs, and CROs — engage with our program leads on translational research.
Company Information
Location
Massachusetts, USA
Stage
Preclinical — Seed Round Open
Focus
Oncology & Antivirals